Cargando…

Management of Severe Graves’ Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis

CONTEXT: Alemtuzumab (ALZ), a CD52 monoclonal antibody, is highly efficacious in multiple sclerosis; however, side effects are common. Autoimmune thyroid disease (Graves’ disease and Hashimoto thyroiditis) is a well-known complication of ALZ. Treatment of ALZ-induced Graves’ disease can be challengi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammerstad, Sara Salehi, Celius, Elisabeth G, Husby, Henrik, Sørensen, Ingvild M, Norheim, Ingrid E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122367/ https://www.ncbi.nlm.nih.gov/pubmed/34017934 http://dx.doi.org/10.1210/jendso/bvab044

Ejemplares similares

Graves’ hyperthyroidism in pregnancy: a clinical review
por: Nguyen, Caroline T., et al.
Publicado: (2018)

The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)

Pulsed immune reconstitution therapy in multiple sclerosis
por: Sorensen, Per Soelberg, et al.
Publicado: (2019)

Breastfeeding and treatment of multiple sclerosis
por: Celius, Elisabeth G
Publicado: (2020)

The importance of an individual approach to Graves’ hyperthyroidism
por: Bednarczuk, Tomasz
Publicado: (2015)

Alternating hyperthyroidism and hypothyroidism in Graves’ disease
por: Wong, Mimi, et al.
Publicado: (2018)

New Therapeutic Horizons for Graves’ Hyperthyroidism
por: Lane, Laura C, et al.
Publicado: (2020)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Toward Ultimate Care for Graves’ Hyperthyroidism
por: Azizi, Fereidoun, et al.
Publicado: (2019)

Pregnancy Outcomes among Women with Graves’ Hyperthyroidism: A Retrospective Cohort Study
por: Harn-a-morn, Panwad, et al.
Publicado: (2021)

Current and emerging treatment options for Graves’ hyperthyroidism
por: Abraham, Prakash, et al.
Publicado: (2010)

Hyperthyroidism and Graves’ disease: Is an ultrasound examination needed?
por: Varadhan, Lakshminarayanan, et al.
Publicado: (2016)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Thyroid Function During Pregnancy in A Multiethnic Population in Norway
por: Sletner, Line, et al.
Publicado: (2021)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease
por: Weider, Therese, et al.
Publicado: (2020)

Pancytopenia with cellular bone marrow related to Graves’ hyperthyroidism
por: Raina, Sujeet, et al.
Publicado: (2012)

Radioiodine Thyroid Ablation in Graves’ Hyperthyroidism: Merits and Pitfalls
por: Nwatsock, J. F., et al.
Publicado: (2012)

A patient-specific treatment model for Graves’ hyperthyroidism
por: Pandiyan, Balamurugan, et al.
Publicado: (2018)

COVID-19: a cause of recurrent Graves’ hyperthyroidism?
por: Jiménez-Blanco, S., et al.
Publicado: (2020)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Unilateral gynecomastia as an initial presentation of hyperthyroid Graves’ disease
por: Sakulterdkiat, Titipatima, et al.
Publicado: (2021)

Urticarial vasculitis in a young woman with Graves hyperthyroidism
por: Hung, Yi-Teng, et al.
Publicado: (2022)

AZD-1222: Aggravation of Graves hyperthyroidism: case report
Publicado: (2022)

Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation
por: McAninch, Elizabeth A, et al.
Publicado: (2023)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

Pregnancy and Hyperthyroidism
Publicado: (1931)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Efficacy of low-dose methimazole in control of multiple relapses of Graves’ hyperthyroidism: a case report
por: Azizi, Fereidoun, et al.
Publicado: (2021)

The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves’ disease
por: Chang, Xiaona, et al.
Publicado: (2023)

Thyroid Function after Subtotal Thyroidectomy in Patients with Graves' Hyperthyroidism
por: Limonard, E. J., et al.
Publicado: (2012)

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020)

Tozinameran: Recurrence of hyperthyroidism secondary to Graves' disease: case report
Publicado: (2021)

Prediction for recurrence following antithyroid drug therapy for Graves’ hyperthyroidism
por: Weng, Huan, et al.
Publicado: (2023)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

Management of hyperthyroidism in pregnancy
por: Grigoriu, C, et al.
Publicado: (2008)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Persistent hyperthyroidism and de novo Graves’ ophthalmopathy after total thyroidectomy
por: Tay, Wei Lin, et al.
Publicado: (2017)

Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model
por: Schlüter, Anke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_brjs9nmcol1pcvms8r1d228inn